Current evidence on the effects of palm oil consumption on biomarkers of glucose metabolism is poor and limited to only healthy participants .
We conclude that little or no additional benefit will be obtained by replacing palm oil with other oils rich in mono or polyunsaturated fatty acids for changes in glucose metabolism
INTRODUCTION Vegetable oil is an important source of fatty acids , and as palm oil being the highest consumed vegetable oil in many countries , its high saturated fatty acid content has led many concerns on cardiometabolic health .
Dietary fatty acids has also been linked to affect glucose metabolism and insulin sensitivity .
This systematic review is aim ed at critically evaluating the available evidence on the association of palm oil with the biomarkers of glucose metabolism as compared to other vegetable oils .
Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort: associations by types, sources of fatty acids and substitution by macronutrients
Purpose The association between dietary saturated fatty acids ( SFA ) intake and  type 2 diabetes ( T2D )  remains unclear . This study aim ed at investigating the association between SFA intake and T2D risk based on ( 1 ) individual SFA ( differing in carbon chain length ) , ( 2 ) food sources of SFA and ( 3 ) the substituting macronutrients . Methods 37,421 participants from the European Prospect i ve Investigation into Cancer and Nutrition-Netherl and s ( EPIC-NL ) cohort were included in this study . Baseline dietary intake was assessed by a vali date d food frequency question naire . T2D risks were estimated by Cox regression models adjusted for non-dietary and dietary covariates . Results 893 incident T2D cases were documented during 10.1-year follow-up . We observed no association between total SFA and T2D risk . Marginally inverse associations were found for lauric acid ( HR per 1 SD of energy% , 95 % CI 0.92 , 0.85–0.99 ) , myristic acid ( 0.89 , 0.79–0.99 ) , margaric acid ( 0.84 , 0.73–0.97 ) , odd-chain SFA ( pentadecylic plus margaric acids ; 0.88 , 0.79–0.99 ) , and cheese derived SFA ( 0.90 , 0.83–0.98 ) . Soft and liquid fats derived SFA was found related to higher T2D risk ( 1.08 , 1.01–1.17 ) . When substituting SFA by proteins , carbohydrates and polyunsaturated fatty acids , significantly higher risks of T2D were observed ( HRs per 1 energy% ranging from 1.05 to 1.15 ) . Conclusion In this Dutch population , total SFA does not relate to T2D risk . Rather , the association may depend on the types and food sources of SFA . Cheese-derived SFA and individual SFA that are commonly found in cheese , were significantly related to lower T2D risks . We can not exclude the higher T2D risks found for soft and liquid fats derived SFA and for substituting SFA with other macronutrients are influenced by residual confounding by trans fatty acids or limited intake variation in polyunsaturated fatty acids and vegetable protein
Current evidence on the effects of palm oil consumption on biomarkers of glucose metabolism is poor and limited to only healthy participants .
We conclude that little or no additional benefit will be obtained by replacing palm oil with other oils rich in mono or polyunsaturated fatty acids for changes in glucose metabolism
INTRODUCTION Vegetable oil is an important source of fatty acids , and as palm oil being the highest consumed vegetable oil in many countries , its high saturated fatty acid content has led many concerns on cardiometabolic health .
Dietary fatty acids has also been linked to affect glucose metabolism and insulin sensitivity .
This systematic review is aim ed at critically evaluating the available evidence on the association of palm oil with the biomarkers of glucose metabolism as compared to other vegetable oils .